$40.23 (0.638%)

Volume: 85.047k

Closed: Dec 02, 2022

Hollow Logo Score: -2.199

Galapagos NV Stock Forecast

$40.23 (0.638%)

Volume: 85.047k

Closed: Dec 02, 2022

Score Hollow Logo -2.199

Galapagos NV Stock Statistics NASDAQ:GLPG

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-11-25 - 2022-12-02 SELL -1.11
2022-11-23 - 2022-11-25 HOLD -0.416
2022-11-04 - 2022-11-23 SELL -4.44
2022-10-25 - 2022-11-04 BUY -5.29
2022-10-24 - 2022-10-25 SELL 0.445

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT